Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Immunosuppressive or Immunomodulatory Agents on Severe COVID-19 Outcomes: A Population-Based Cohort Study.
Marozoff S, Tan J, Lu N, Kirmani A, Loree JM, Xie H, Lacaille D, Kopec JA, Esdaile JM, Corradetti B, Malone P, Koehn CL, Mennell P, Hoens AM, Aviña-Zubieta JA. Marozoff S, et al. Among authors: lacaille d. ACR Open Rheumatol. 2023 Dec;5(12):685-693. doi: 10.1002/acr2.11620. Epub 2023 Oct 11. ACR Open Rheumatol. 2023. PMID: 37818772 Free PMC article.
System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002-2019.
Barber CEH, Lacaille D, Croxford R, Barnabe C, Marshall DA, Abrahamowicz M, Xie H, Avina-Zubieta JA, Esdaile JM, Hazlewood G, Faris P, Katz S, MacMullan P, Mosher D, Widdifield J. Barber CEH, et al. Among authors: lacaille d. BMC Rheumatol. 2022 Dec 27;6(1):86. doi: 10.1186/s41927-022-00315-6. BMC Rheumatol. 2022. PMID: 36572934 Free PMC article.
Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis.
Zhou VY, Lacaille D, Lu N, Kopec JA, Qian Y, Nosyk B, Aviña-Zubieta JA, Esdaile JM, Xie H. Zhou VY, et al. Among authors: lacaille d. Rheumatology (Oxford). 2023 Dec 1;62(12):3858-3865. doi: 10.1093/rheumatology/kead158. Rheumatology (Oxford). 2023. PMID: 37014364 Free PMC article.
Response to: Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" by Boers.
Studenic P, Aletaha D, Stamm TA, de Wit M, Lacaille D, Smolen JS, Felson D. Studenic P, et al. Among authors: lacaille d. Ann Rheum Dis. 2023 Sep;82(9):e202. doi: 10.1136/ard-2022-223627. Epub 2023 Apr 20. Ann Rheum Dis. 2023. PMID: 37080713 No abstract available.
National burden of rheumatoid arthritis in Canada, 1990-2019: findings from the Global Burden of Disease Study 2019 - a GBD collaborator-led study.
Hassen N, Lacaille D, Xu A, Alandejani A, Sidi S, Mansourian M, Butt ZA, Cahill LE, Iyamu IO, Lang JJ, Rana J, Somayaji R, Sarrafzadegan N, Kopec JA; GBD RA Collaborator Group. Hassen N, et al. Among authors: lacaille d. RMD Open. 2024 Jan 12;10(1):e003533. doi: 10.1136/rmdopen-2023-003533. RMD Open. 2024. PMID: 38216285 Free PMC article.
160 results